Skip to main content

Table 1 Main methodological limitations of the studies considering AIT in asthma

From: Allergen immunotherapy in asthma; what is new?

ITEM

CRITICAL ASPECTS

Patients’ selection

Patients should be selected matching asthma severity and, current asthma therapy

Primary outcome

Asthma-related parameters should be the primary outcome

Sample size calculation

Based on asthma-related primary outcome

Objective parameters

Pulmonary function tests/bronchial challenges should be included in primary outcomes

AIT protocol

Should be uniformed (duration, doses, run-in etc.)

Duration

An optimal duration of the AIT course is not established

Dose

The optimal maintenance dose needs to be established for most allergens. Discrepancies among manufacturers